Effect of Interferential Therapy on SARS-CoV-2. COVID-19

Efficacy of Interferential Therapy on Selected Cardiopulmonary Parameters of Asthmatic Patients with Post COVID-9 Exposure

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202006717277937

Enrollment

Registered

2020-06-10

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory

Interventions

IFT WITH SABA IN 45 DEGREES LONG SITTING POSITION

IFT WITH SABA IN 9O DEGREES LONG SITTING POSITION

IFT WITH SABA AND STEROIDS IN 45 DEGREES LONG SITTING POSITION

IFT WITH SABA AND STEROIDS IN 90 DEGREES LONG SITTING POSITION

IFT WITH SABA AND STEROIDS IN 45 DEGREES LONG SITTING.

IFT WITH SABA IN 90 DEGREES LONG SITTING POSITION

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Individuals above the Age of 10 years ? Individuals with bronchial asthma ? Individuals exposed to SARS-CoV-2 virus ? Individuals that has been isolated at the NCDC accredited centre

Exclusion criteria

Exclusion criteria: ? Those on cardiac pacemaker ? Those with cardiac conditions ? Those with other types of COPD other than bronchial asthma ? Those on supplemental oxygen therapy ? Those with psychological disorders ? Those with status asthmaticus ? Those that are under 10 years

Design outcomes

Primary

Measure	Time frame
PULMONARY FUNCTION TEST	—

Secondary

Measure	Time frame
ASTHMA CONTROL TEST, ASTHMA QUALITY OF LIFE	—

Countries

Nigeria

Contacts

Public ContactSonill Maharaj

Supervisor

maharajss@ukzn.ac.za+27834611413

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026